Matt Calistri | Vice President, Investor Relations |
Michel Vounatsos | Chief Executive Officer |
Michael Ehlers | Executive Vice President of Research & Development |
Jeff Capello | Chief Financial Officer |
Ying Huang | Bank of America. Merrill Lynch |
Robyn Karnauskas | Citigroup |
Geoff Meacham | Barclays |
Michael Yee | Jefferies |
Cory Kasimov | JPMorgan |
Umer Raffat | Evercore |
Alethia Young | Cantor Fitzgerald |
Geoffrey Porges | Leerink |
Carter Gould | UBS |
Phil Nadeau | Cowen and Company |
Ronny Gal | Bernstein |
Terence Flynn | Goldman Sachs |
Good morning. My name is Jessa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen First Quarter 2019 Financial Results and Business Update. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.